Displaying 1 - 10 of 13155
Drupal spam blocked by CleanTalk.
Author year
In vitro activity of olorofim (F901318) against clinical isolates of cryptic species of Aspergillus by EUCAST and CLSI methodologies. Rivero-Menendez O, Cuenca-Estrella M, Alastruey-Izquierdo A. 2019
Clinical features and cause analysis of false positive results of Aspergillus galactomannan assay in pulmonary cryptococcosis patients. Takazono T, Saijo T, Ashizawa N, Oshima K, Nishimura K, Tashiro M, Yamamoto K, Imamura Y, Miyazaki T, Yanagihara K, Mukae H, Izumikawa K, Sheppard DC. 2019
Aerosol Transmission of Aspergillus fumigatus in Cystic Fibrosis Patients in the Netherlands Tobias G.P. Engel, Ellen Erren, Koen S.J. Vanden Driessche, Willem J.G. Melchers, Monique H. Reijers, Peter Merkus, and Paul E. Verweij 2019
Posaconazole for the treatment of allergic bronchopulmonary aspergillosis in patients with cystic fibrosis. Periselneris J, Nwankwo L, Schelenz S, Shah A, Armstrong-James D. 2019
Exogenous Stimulation of Type I Interferon Protects Mice with Chronic Granulomatous Disease from Aspergillosis through Early Recruitment of Host-Protective Neutrophils into the Lung. Seyedmousavi S, Davis MJ, Sugui JA, Pinkhasov T, Moyer S, Salazar AM, Chang YC, Kwon-Chung KJ. 2019
Helper T-cell responses and pulmonary fungal infections. McDermott AJ, Klein BS. 2019
Detection of deep fungal infections: a polyphasic approach. Sabino R, Simões H, Veríssimo C. 2019
Airway Colonization by Candida and Aspergillus species in Iranian Cystic Fibrosis Patients. Nasri E, Fakhim H, Vaezi A, Khalilzadeh S, Ahangarkani F, Laal Kargar M, Abtahian Z, Badali H. 2019
Correlation of CYP2C19 genotype with plasma voriconazole exposure in South-western Chinese Han patients with invasive fungal infections. Miao Q, Tang JT, van Gelder T, Li YM, Bai YJ, Zou YG, Wang LL, Shi YY. 2019
Antiviral activity of itraconazole against type I feline coronavirus infection. Takano T, Akiyama M, Doki T, Hohdatsu T. 2019


Subscribe to Search